This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2015 Sep 19;386(9999):1135-6.

doi: 10.1016/S0140-6736(15)00204-4.

Oseltamivir for influenza - Authors' reply

Arnold S Monto¹, Joanna Dobson², Stuart Pocock², Richard J Whitley³

Affiliations

Affiliations

¹ Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, MI 48109-2029, USA. Electronic address: asmonto@umich.edu.
² Department of Medical Statistics, London School of Hygiene & Tropical Medicine, London, UK.
³ Department of Pediatrics, Microbiology, Medicine and Neurosurgery, University of Alabama at Birmingham, Birmingham, AL, USA.

PMID: 26461902
DOI: 10.1016/S0140-6736(15)00204-4

Comment

Oseltamivir for influenza - Authors' reply

Arnold S Monto et al. Lancet. 2015.

. 2015 Sep 19;386(9999):1135-6.

doi: 10.1016/S0140-6736(15)00204-4.

Authors

Arnold S Monto¹, Joanna Dobson², Stuart Pocock², Richard J Whitley³

Affiliations

¹ Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, MI 48109-2029, USA. Electronic address: asmonto@umich.edu.
² Department of Medical Statistics, London School of Hygiene & Tropical Medicine, London, UK.
³ Department of Pediatrics, Microbiology, Medicine and Neurosurgery, University of Alabama at Birmingham, Birmingham, AL, USA.

PMID: 26461902
DOI: 10.1016/S0140-6736(15)00204-4

No abstract available

PubMed Disclaimer

Comment on

Oseltamivir treatment for influenza in adults: a meta-analysis of randomised controlled trials.
Dobson J, Whitley RJ, Pocock S, Monto AS. Dobson J, et al. Lancet. 2015 May 2;385(9979):1729-1737. doi: 10.1016/S0140-6736(14)62449-1. Epub 2015 Jan 30. Lancet. 2015. PMID: 25640810 Review.
Oseltamivir for influenza.
Jones M, Hama R, Del Mar C. Jones M, et al. Lancet. 2015 Sep 19;386(9999):1133-4. doi: 10.1016/S0140-6736(15)00200-7. Lancet. 2015. PMID: 26461897 No abstract available.
Oseltamivir for influenza.
Doshi P, Heneghan C, Jefferson T. Doshi P, et al. Lancet. 2015 Sep 19;386(9999):1134-5. doi: 10.1016/S0140-6736(15)00202-0. Lancet. 2015. PMID: 26461899 No abstract available.
Oseltamivir for influenza.
Radecki RP. Radecki RP. Lancet. 2015 Sep 19;386(9999):1134. doi: 10.1016/S0140-6736(15)00201-9. Lancet. 2015. PMID: 26461900 No abstract available.
Oseltamivir for influenza.
Kubo K, Otsu S, Komiya N. Kubo K, et al. Lancet. 2015 Sep 19;386(9999):1135. doi: 10.1016/S0140-6736(15)00203-2. Lancet. 2015. PMID: 26461901 No abstract available.

Similar articles

Oseltamivir for influenza - Authors' reply.
Monto AS, Dobson J, Pocock S, Whitley RJ. Monto AS, et al. Lancet. 2016 Jan 9;387(10014):125. doi: 10.1016/S0140-6736(15)01280-5. Epub 2016 Jan 8. Lancet. 2016. PMID: 26841996 No abstract available.
Oseltamivir for influenza.
Doshi P, Heneghan C, Jefferson T. Doshi P, et al. Lancet. 2016 Jan 9;387(10014):124. doi: 10.1016/S0140-6736(15)01282-9. Epub 2016 Jan 8. Lancet. 2016. PMID: 26841993 No abstract available.
Oseltamivir for influenza.
Kubo K, Otsu S, Komiya N. Kubo K, et al. Lancet. 2015 Sep 19;386(9999):1135. doi: 10.1016/S0140-6736(15)00203-2. Lancet. 2015. PMID: 26461901 No abstract available.
Oseltamivir treatment for influenza in adults: a meta-analysis of randomised controlled trials.
Dobson J, Whitley RJ, Pocock S, Monto AS. Dobson J, et al. Lancet. 2015 May 2;385(9979):1729-1737. doi: 10.1016/S0140-6736(14)62449-1. Epub 2015 Jan 30. Lancet. 2015. PMID: 25640810 Review.
Oseltamivir: the real world data.
Freemantle N, Shallcross LJ, Kyte D, Rader T, Calvert MJ. Freemantle N, et al. BMJ. 2014 Apr 9;348:g2371. doi: 10.1136/bmj.g2371. BMJ. 2014. PMID: 24811409 Review. No abstract available.

See all similar articles

Cited by

Why European and United States drug regulators are not speaking with one voice on anti-influenza drugs: regulatory review methodologies and the importance of 'deep' product reviews.
Mulinari S, Davis C. Mulinari S, et al. Health Res Policy Syst. 2017 Nov 9;15(1):93. doi: 10.1186/s12961-017-0259-8. Health Res Policy Syst. 2017. PMID: 29121959 Free PMC article.
Efficacy of oseltamivir compared with zanamivir in COPD patients with seasonal influenza virus infection: a randomized controlled trial.
Li M, Han GC, Chen Y, Du WX, Liu F, Chi YM, Du JF. Li M, et al. Braz J Med Biol Res. 2020 Nov 27;54(2):e9542. doi: 10.1590/1414-431X20209542. eCollection 2020. Braz J Med Biol Res. 2020. PMID: 33263644 Free PMC article. Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information